Tarkka M R, Vuolle M, Kaukinen S, Holm P, Eloranta J, Kaukinen U, Sisto T, Kataja J
Department of Cardiovascular Surgery, Tampere University Hospital, Finland.
Scand Cardiovasc J. 2000 Dec;34(6):593-6. doi: 10.1080/140174300750064549.
Allopurinol protects the heart from reperfusion injury. The aim of this study was to investigate myocardial free radical production during reperfusion with and without allopurinol treatment in coronary artery bypass grafting patients randomized into allopurinol (n = 14) or placebo (n = 13) groups.
Allopurinol (1 g) was given blind prior to cardiopulmonary bypass and prior to opening the aorta. Oxygen free radicals were measured before anesthesia in arterial blood, before cross-clamping and 1 and 10 min after reperfusion in arterial and coronary sinus blood. Levels were measured as relative concentrations by the electron spin resonance method.
One minute after reperfusion the level of spin-trapped radicals in arterial blood was elevated significantly (p = 0.016) in the allopurinol group, from 7.7 (SE: 0.8) to 8.6 (1.4) and non-significantly (p = 0.074) in the placebo group, from 7.3 (0.7) to 8.3 (0.8). Ten minutes after reperfusion the arterial values were 8.6 (1.5) in the allopurinol and 7.6 (0.7) in the placebo group, the sinus values being 7.6 (1.3) and 8.3 (0.8), respectively. Myocardial free radical production was -0.94 (1.21) in the allopurinol and +0.79 (0.96) in the placebo group after 10 min reperfusion, the difference being significant (p = 0.043).
All patients in both groups had an increasing tendency to free radical production during early reperfusion. Patients treated with allopurinol showed less myocardial production of free radicals, indicating that its protective effect may be due to its antioxidative properties.
别嘌醇可保护心脏免受再灌注损伤。本研究旨在调查在冠状动脉搭桥手术患者中,随机分为别嘌醇组(n = 14)或安慰剂组(n = 13),在有或没有别嘌醇治疗的情况下再灌注期间心肌自由基的产生情况。
在体外循环前和打开主动脉前,盲目给予别嘌醇(1 g)。在麻醉前于动脉血中、在阻断血流前以及再灌注1分钟和10分钟后于动脉血和冠状窦血中测量氧自由基。通过电子自旋共振法将水平测量为相对浓度。
再灌注1分钟后,别嘌醇组动脉血中自旋捕获自由基水平显著升高(p = 0.016),从7.7(标准误:0.8)升至8.6(1.4),而安慰剂组无显著升高(p = 0.074),从7.3(0.7)升至8.3(0.8)。再灌注10分钟后,别嘌醇组动脉血值为8.6(1.5),安慰剂组为7.6(0.7),冠状窦值分别为7.6(1.3)和8.3(0.8)。再灌注10分钟后,别嘌醇组心肌自由基产生为-0.94(1.21),安慰剂组为+0.79(0.96),差异有统计学意义(p = 0.043)。
两组所有患者在早期再灌注期间自由基产生均有增加趋势。接受别嘌醇治疗的患者心肌自由基产生较少,表明其保护作用可能归因于其抗氧化特性。